23
Participants
Start Date
March 19, 2018
Primary Completion Date
July 19, 2019
Study Completion Date
July 19, 2019
SYNB1020
SYNB1020 was supplied at a concentration of approximately 1 × 10\^11 CFU/mL in a buffered solution in 5 mL cryovials with a nominal 5 mL fill volume, administered with 100 mL of masking buffer solution.
Placebo
Subjects received placebo orally in a chilled buffered solution (100 mL).
McGuire VA Medical Center, Richmond
Medical University of South Carolina, Charleston
Texas Liver Institute, San Antonio
Southern California Research Center, Coronado
Inland Empire Liver Foundation, Rialto
Lead Sponsor
Synlogic
INDUSTRY